2011 annual financial data
Silence Therapeutics 2011 Operating margin
Direct answer
Operating margin was -803.46%.
Operating income was -5,786,000 GBP and net income was -5,737,000 GBP.
Operating cash flow was -5,110,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 720,131 GBP
- Operating income
- -5,786,000 GBP
- Net income
- -5,737,000 GBP
- Operating cash flow
- -5,110,000 GBP